Oncora Medical Revenue and Competitors

Location

$5.6M

Total Funding

Estimated Revenue & Valuation

  • Oncora Medical's estimated annual revenue is currently $243k per year.(i)
  • Oncora Medical's estimated revenue per employee is $27,000
  • Oncora Medical's total funding is $5.6M.

Employee Data

  • Oncora Medical has 9 Employees.(i)
  • Oncora Medical grew their employee count by -18% last year.

Oncora Medical's People

NameTitleEmail/Phone
1
CEO, Co-FounderReveal Email/Phone
2
Software EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$47.6M237N/AN/AN/A
#2
$34M218-3%$32MN/A
#3
$2.5M25N/AN/AN/A
#4
$6.8M52N/AN/AN/A
#5
$1.6M18N/AN/AN/A
#6
$24.6M219N/AN/AN/A
#7
$21.3M85N/AN/AN/A
#8
$1.6M18N/AN/AN/A
#9
$11.6M80N/AN/AN/A
#10
$28.1M17628%N/AN/A
#11
$1.5M17N/AN/AN/A
#12
$2.2M22N/AN/AN/A
#13
$1.5M17N/AN/AN/A
#14
$62.4M34432%N/AN/A
#15
$8.2M41N/AN/AN/A
#16
$4.2M22N/AN/AN/A
#17
$1.5M17N/AN/AN/A
Add Company

What Is Oncora Medical?

Software, data, and machine learning to help doctors and scientists in the fight against cancer. Improving care for patients is our top priority.

keywords:N/A

$5.6M

Total Funding

9

Number of Employees

$243k

Revenue (est)

-18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Oncora Medical News

2022-04-13 - How Oncora Medical's CEO realized its product could help ...

How Oncora Medical's CEO realized its product could help with healthcare burnout. The Philly-based healthtech company just brought on two new...

2022-04-13 - Lab Notes: Oncora Medical doubles its client base; Context ...

Lab Notes: Oncora Medical doubles its client base; Context Therapeutics posts promising cancer drug data · Venatorx lands financing; Ocugen...

2022-04-06 - Scripps Health and UT Health San Antonio purchase Oncora's ...

Oncora Medical, Inc. is an oncology patient care company. Oncora builds EHR-integrated software to improve oncologists' workflow and...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M9N/AN/A
#2
$0.2M980%$2M
#3
$1.4M9-44%N/A
#4
$1M9-44%N/A
#5
$0.7M913%N/A